• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米医学在治疗强直性脊柱炎方面的进展。

Advances in nanomedicine for the treatment of ankylosing spondylitis.

机构信息

Department of Spine Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China.

Department of Immunology and Microbiology, Institution of Laboratory Medicine of Changshu, Changshu, Jiangsu 215500, People's Republic of China.

出版信息

Int J Nanomedicine. 2019 Oct 29;14:8521-8542. doi: 10.2147/IJN.S216199. eCollection 2019.

DOI:10.2147/IJN.S216199
PMID:31806960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6831987/
Abstract

Ankylosing spondylitis (AS) is a complex disease characterized by inflammation and ankylosis primarily at the cartilage-bone interface. The disease is more common in young males and risk factors include both genetic and environmental. While the pathogenesis of AS is not completely understood, it is thought to be an immune-mediated disease involving inflammatory cellular infiltrates, and human leukocyte antigen-B27. Currently, there is no specific diagnostic technique available for this disease; therefore conventional diagnostic approaches such as clinical symptoms, laboratory tests and imaging techniques are used. There are various review papers that have been published on conventional treatment approaches, and in this review work, we focus on the more promising nanomedicine-based treatment modalities to move this field forward.

摘要

强直性脊柱炎(AS)是一种以软骨-骨界面炎症和强直为特征的复杂疾病。该病在年轻男性中更为常见,其危险因素包括遗传和环境因素。虽然 AS 的发病机制尚不完全清楚,但它被认为是一种免疫介导的疾病,涉及炎症细胞浸润和人类白细胞抗原-B27。目前,尚无针对这种疾病的特定诊断技术;因此,通常采用临床症状、实验室检查和影像学技术等传统诊断方法。已经发表了许多关于传统治疗方法的综述论文,在这项综述工作中,我们专注于更有前途的基于纳米医学的治疗方法,以推动该领域的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77b/6831987/b775493a45ac/IJN-14-8521-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77b/6831987/ea7232e65296/IJN-14-8521-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77b/6831987/b775493a45ac/IJN-14-8521-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77b/6831987/ea7232e65296/IJN-14-8521-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77b/6831987/b775493a45ac/IJN-14-8521-g0003.jpg

相似文献

1
Advances in nanomedicine for the treatment of ankylosing spondylitis.纳米医学在治疗强直性脊柱炎方面的进展。
Int J Nanomedicine. 2019 Oct 29;14:8521-8542. doi: 10.2147/IJN.S216199. eCollection 2019.
2
[Anti-TNF alfa therapy in ankylosing spondylitis].[抗肿瘤坏死因子α疗法治疗强直性脊柱炎]
Acta Med Port. 2006 Mar-Apr;19(2):141-50. Epub 2006 Aug 18.
3
Spondyloarthritis: update on pathogenesis and management.脊柱关节炎:发病机制与管理的最新进展
Am J Med. 2005 Jun;118(6):592-603. doi: 10.1016/j.amjmed.2005.01.001.
4
Ankylosing spondylitis: a contemporary perspective on diagnosis and treatment.强直性脊柱炎:诊断与治疗的当代观点
Semin Arthritis Rheum. 2007 Feb;36(4):210-23. doi: 10.1016/j.semarthrit.2006.08.003. Epub 2006 Sep 29.
5
[Diagnosis and treatment of ankylosing spondylitis (Bechterew disease)].强直性脊柱炎(贝赫切雷夫病)的诊断与治疗
Dtsch Med Wochenschr. 2005 Aug 19;130(33):1882-6. doi: 10.1055/s-2005-871913.
6
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.阿达木单抗、依那西普和英夫利昔单抗治疗强直性脊柱炎:系统评价与经济学评估
Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. doi: 10.3310/hta11280.
7
Ankylosing spondylitis: an overview.强直性脊柱炎:概述
Ann Rheum Dis. 2002 Dec;61 Suppl 3(Suppl 3):iii8-18. doi: 10.1136/ard.61.suppl_3.iii8.
8
Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.强直性脊柱炎和克罗恩病的关联,经英夫利昔单抗治疗后得到成功缓解。
BioDrugs. 2010 Dec 14;24 Suppl 1:37-9. doi: 10.2165/11586220-000000000-00000.
9
The role of secukinumab in the treatment of ankylosing spondylitis.司库奇尤单抗在强直性脊柱炎治疗中的作用。
Immunotherapy. 2015;7(12):1241-7. doi: 10.2217/imt.15.93. Epub 2015 Nov 23.
10
[Ankylosing spondylitis].[强直性脊柱炎]
Nihon Rinsho. 2005 May;63 Suppl 5:365-9.

引用本文的文献

1
ASNET: A Novel AI Framework for Accurate Ankylosing Spondylitis Diagnosis from MRI.ASNET:一种用于从MRI准确诊断强直性脊柱炎的新型人工智能框架。
Biomedicines. 2023 Sep 1;11(9):2441. doi: 10.3390/biomedicines11092441.
2
Exploring hub pyroptosis-related genes, molecular subtypes, and potential drugs in ankylosing spondylitis by comprehensive bioinformatics analysis and molecular docking.通过综合生物信息学分析和分子对接技术探索强直性脊柱炎中枢纽炎性细胞焦亡相关基因、分子亚型和潜在药物。
BMC Musculoskelet Disord. 2023 Jun 29;24(1):532. doi: 10.1186/s12891-023-06664-8.
3
Functional mechanism of miR-92b-3p in osteogenic differentiation of fibroblasts in patients with ankylosing spondylitis via the TOB1/BMP/Smad pathway.

本文引用的文献

1
Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy.利用明胶纳米载体递送至肺部治疗肺癌的甲氨蝶呤。
Eur J Pharm Sci. 2019 May 15;133:115-126. doi: 10.1016/j.ejps.2019.03.016. Epub 2019 Mar 21.
2
Challenging Management of Hepatitis B infection in Ankylosing Spondylitis Patients in an Endemic Area during Immunosuppressive Therapy.地方流行区强直性脊柱炎患者在免疫抑制治疗期间乙型肝炎感染的挑战性管理
Rev Soc Bras Med Trop. 2019 Mar 18;52:e20180386. doi: 10.1590/0037-8682-0386-2018.
3
Drug nanocrystals: Fabrication methods and promising therapeutic applications.
miR-92b-3p 通过 TOB1/BMP/Smad 通路在强直性脊柱炎患者成纤维细胞成骨分化中的功能机制。
J Orthop Surg Res. 2023 Jun 2;18(1):402. doi: 10.1186/s13018-023-03850-1.
4
LncRNA HOTTIP impacts the proliferation and differentiation of fibroblast-like synoviocytes in ankylosing spondylitis through the microRNA-30b-3p/PGK1 axis.长链非编码 RNA HOTTIP 通过 microRNA-30b-3p/PGK1 轴影响强直性脊柱炎成纤维样滑膜细胞的增殖和分化。
J Orthop Surg Res. 2023 Mar 24;18(1):237. doi: 10.1186/s13018-023-03653-4.
5
Comprehensive AI-assisted tool for ankylosing spondylitis based on multicenter research outperforms human experts.基于多中心研究的强直性脊柱炎综合人工智能辅助工具优于人类专家。
Front Public Health. 2023 Feb 9;11:1063633. doi: 10.3389/fpubh.2023.1063633. eCollection 2023.
6
A brief human history of ankylosing spondylitis: A scoping review of pathogenesis, diagnosis, and treatment.强直性脊柱炎的简要人类病史:发病机制、诊断与治疗的范围综述
Surg Neurol Int. 2022 Jul 15;13:297. doi: 10.25259/SNI_294_2022. eCollection 2022.
7
The Molecular Mechanism of Long Non-Coding RNA MALAT1-Mediated Regulation of Chondrocyte Pyroptosis in Ankylosing Spondylitis.长链非编码 RNA MALAT1 介导调控强直性脊柱炎软骨细胞焦亡的分子机制。
Mol Cells. 2022 Jun 30;45(6):365-375. doi: 10.14348/molcells.2022.2081.
8
Nanotechnology applications in rheumatology.纳米技术在风湿病学中的应用。
Rheumatol Int. 2022 Nov;42(11):1883-1891. doi: 10.1007/s00296-022-05141-0. Epub 2022 May 19.
9
Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritis.跨膜TNF驱动的人类脊柱关节炎模型中的异位骨形成和全身性骨质流失。
Arthritis Res Ther. 2020 Oct 6;22(1):232. doi: 10.1186/s13075-020-02327-4.
10
Efficacy of alendronate for the treatment of ankylosing spondylitis: A protocol for systematic review and meta-analysis.阿仑膦酸钠治疗强直性脊柱炎的疗效:一项系统评价与荟萃分析方案
Medicine (Baltimore). 2020 Jul 24;99(30):e21089. doi: 10.1097/MD.0000000000021089.
药物纳米晶体:制备方法及有前途的治疗应用。
Int J Pharm. 2019 May 1;562:187-202. doi: 10.1016/j.ijpharm.2019.02.045. Epub 2019 Mar 6.
4
Disease-Modifying Effects of Long-Term and Continuous Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Spondyloarthritis.长期持续使用非甾体抗炎药(NSAIDs)对脊柱关节炎的病情改善作用
Adv Pharmacol Sci. 2019 Jan 29;2019:5324170. doi: 10.1155/2019/5324170. eCollection 2019.
5
Chitosan based thermosensitive injectable hydrogels for controlled delivery of loxoprofen: development, characterization and in-vivo evaluation.壳聚糖基温敏型注射水凝胶用于洛索洛芬的控制释放:制备、表征和体内评价。
Int J Biol Macromol. 2019 May 15;129:233-245. doi: 10.1016/j.ijbiomac.2019.02.031. Epub 2019 Feb 6.
6
Self-assembled peptide-poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis.自组装肽-聚氧乙烯纳米粒可实现囊性纤维化的体外和体内基因组修复。
Nat Nanotechnol. 2019 Mar;14(3):287-297. doi: 10.1038/s41565-018-0358-x. Epub 2019 Jan 28.
7
Methotrexate for psoriatic arthritis.甲氨蝶呤用于治疗银屑病关节炎。
Cochrane Database Syst Rev. 2019 Jan 18;1(1):CD012722. doi: 10.1002/14651858.CD012722.pub2.
8
Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer.基于载药-药物策略的紫杉醇和双硫仑共递送用于治疗多药耐药性癌症。
Int J Pharm. 2019 Feb 25;557:304-313. doi: 10.1016/j.ijpharm.2018.12.067. Epub 2018 Dec 29.
9
Surgical management of spinal fractures in ankylosing spondylitis.强直性脊柱炎脊柱骨折的外科治疗
J Spine Surg. 2018 Sep;4(3):501-508. doi: 10.21037/jss.2018.06.15.
10
Topical delivery of 3,5,4'-trimethoxy-trans-stilbene-loaded microemulsion-based hydrogel for the treatment of osteoarthritis in a rabbit model.载 3,5,4'-三甲氧基反式-二苯乙烯的微乳凝胶经皮给药治疗兔骨关节炎模型。
Drug Deliv Transl Res. 2019 Feb;9(1):357-365. doi: 10.1007/s13346-018-00604-z.